We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Freeport-McMoran
FCX
$91.2B
| $7M | 0.05% |
628,598
+64,194
| +11% | +$711K |
|
|
TTM
402
DELISTED
Tata Motors Limited
TTM
| $6.96M | 0.05% |
200,692
+24,233
| +14% | +$759K |
|
403
Vertex Pharmaceuticals
VRTX
$122B
| $6.95M | 0.05% |
80,764
+12,255
| +18% | +$1.06M |
|
404
Molson Coors Class B
TAP
$7.79B
| $6.9M | 0.05% |
68,212
+3,569
| +6% | +$351K |
|
405
Brookfield
BN
$103B
| $6.88M | 0.05% |
583,243
-103,766
| -15% | -$1.24M |
|
406
Range Resources
RRC
$9.24B
| $6.87M | 0.05% |
159,264
-787
| -0.5% | -$32.2K |
|
407
Affiliated Managers Group
AMG
$9.65B
| $6.86M | 0.05% |
48,753
-629
| -1% | -$103K |
|
408
Assurant
AIZ
$14B
| $6.85M | 0.05% |
79,364
+5,791
| +8% | +$486K |
|
|
TEF
409
DELISTED
Telefonica
TEF
| $6.85M | 0.05% |
929,490
-76,892
| -8% | -$617K |
|
410
Quest Diagnostics
DGX
$25.9B
| $6.76M | 0.05% |
82,983
+13,793
| +20% | +$1.05M |
|
411
Ventas
VTR
$44.7B
| $6.72M | 0.05% |
92,224
+13,265
| +17% | +$874K |
|
412
Agnico Eagle Mines
AEM
$75.4B
| $6.67M | 0.05% |
124,606
+88
| +0.1% | +$4K |
|
|
CERN
413
DELISTED
Cerner Corp
CERN
| $6.66M | 0.05% |
113,642
+22,193
| +24% | +$1.24M |
|
|
KYO
414
DELISTED
Kyocera Adr
KYO
| $6.64M | 0.05% |
139,399
+10,724
| +8% | +$516K |
|
415
NiSource
NI
$21.6B
| $6.63M | 0.05% |
249,907
+2,136
| +0.9% | +$51.3K |
|
416
Western Digital
WDC
$184B
| $6.63M | 0.05% |
185,528
+83,919
| +83% | +$2.76M |
|
|
BBBY
417
DELISTED
Bed Bath & Beyond Inc
BBBY
| $6.62M | 0.05% |
153,123
+66,745
| +77% | +$3.03M |
|
418
LG Display
LPL
$2.98B
| $6.6M | 0.05% |
569,762
+111,554
| +24% | +$1.2M |
|
|
FL
419
DELISTED
Foot Locker
FL
| $6.6M | 0.05% |
120,324
+79,610
| +196% | +$4.62M |
|
420
Regions Financial
RF
$26.3B
| $6.58M | 0.05% |
773,568
+13,656
| +2% | +$124K |
|
421
Vornado Realty Trust
VNO
$7.55B
| $6.52M | 0.05% |
80,599
+2,957
| +4% | +$229K |
|
422
Dover
DOV
$27.5B
| $6.52M | 0.05% |
116,422
+3,508
| +3% | +$189K |
|
|
FITB
423
Fifth Third Bancorp
FITB
$51.3B
| $6.52M | 0.05% |
370,508
+1,277
| +0.3% | +$22.9K |
|
|
CIM
424
Chimera Investment
CIM
$1.06B
| $6.51M | 0.05% |
138,172
+15,510
| +13% | +$685K |
|
425
Tenaris
TS
$28.6B
| $6.49M | 0.05% |
225,022
+60,283
| +37% | +$1.6M |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.